Skip to main content

Heikki Lanckriet

Sygnis has appointed Heikki Lanckriet as co-CEO and CSO, the latter being a newly created position at the company. Lanckriet is currently CEO of Expedeon Holdings, which he co-founded in 2003, and where he has served as CSO and Chief Operating Officer. Lanckriet will also become a member of Sygnis' management board along with Pilar de la Huerta, who will serve as co-CEO and CFO of the company.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.